Search the Newsreel

Cosmos Health Inc (COSM) Institutional Confidence

Cosmos Health Inc (COSM) has an institutional shareholding score of 3.00, placing it 92nd out of 155 in the Pharmaceuticals industry. The institutional shareholding proportion is 2.84%, a 67.39% decrease quarter-over-quarter. James Simons is the largest institutional shareholder, holding 0.78% of outstanding shares.

Cosmos Health Inc (COSM) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of Cosmos Health Inc (COSM) stock, focusing on its dividend history and stock splits. It states that the company has not distributed any dividends over the past five years. The article also details multiple stock merger events that occurred …

Cosmos Health Inc (COSM) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a revenue breakdown for Cosmos Health Inc (COSM), focusing on its regional revenue contributions. As of the updated report on April 6, the company's revenue is predominantly generated from Greece, accounting for 95.77% of total revenue. Other contributing regions include the …

Cosmos Health Inc (COSM) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Cosmos Health Inc (COSM), outlining its major individual and institutional holders. It provides a breakdown of shareholder types, institutional holdings over several quarters, and recent shareholder activity with changes in their stake. Key shareholders include Grigorios Siokas, …

Cosmos Machinery Enterprises Limited Revenue Breakdown – HKEX:118

COSM|Cosmos Health Inc|Price:0.206|Chg%: +0.006

Cosmos Health Inc. (COSM) is trading at $0.200 per share with a market capitalization of $8.21 million. The company's fundamentals are considered stable with high growth potential, and its valuation is seen as fairly valued within the Pharmaceuticals industry. Institutional ownership is high, though …

Cosmo N.V. bestätigt Ergebnisprognose für das Gesamtjahr 2026

Cosmos Health | RW: Registration Withdrawal Request

This moomoo community post, created by user DrJaguar8, discusses Cosmos Health (COSM.US) in the context of a "Registration Withdrawal Request." The post is brief, acting as a prompt for discussion rather than an in-depth analysis. It includes a disclaimer stating that the content is …

Cosmos Health Inc. SEC Filing (Jul 22, 2026)

Cosmos Health Inc. (COSM) has formally requested the withdrawal of its Registration Statement on Form S-3 (File No. 333-290420), originally filed on September 19, 2025, with the Securities and Exchange Commission. The Company states that the Registration Statement has not been declared effective and …

COSM stock trades around recent lows as Cosmos Health focuses on integrating acquisitions and stabil

Cosmos Health Inc. (COSM) stock is trading around recent lows as the company shifts its focus to integrating past acquisitions, stabilizing operations, and repairing its balance sheet. The article highlights the importance of revenue traction, margin development, and balance-sheet flexibility for investors, moving away …

Cosmos Health Expands Pharma Cell Partnership in Albania with Annualized Orders Projected to Exceed 54,000 Units

Cosmos Health Inc. has expanded its partnership with Pharma Cell for the distribution of its Sky Premium Life brand in Albania, projecting annualized orders to exceed 54,000 units. This expansion builds on a successful partnership launched in April 2025, driven by strong market reception …

Cosmos Health launches subscription model for health products By Investing.com

Cosmos Health Inc. (NASDAQ: COSM) has launched a subscription-based purchasing model for its consumer health brands, starting with NOOR Collagen in the United States. Early results show a more than 60% repeat purchase rate and over 50% margins, significantly improving upon the company's overall …

Cosmos Health (COSM) Stock Forecast & Analyst Ratings

This article provides a stock forecast and analyst ratings for Cosmos Health (COSM). It examines various financial metrics and analyst price targets to assess the company's future stock performance.

Cosmos Health repurchases 274,000 shares under buyback program

Cosmos Health Inc. has repurchased an additional 274,000 shares of its common stock at an average price of $0.2554 per share, bringing the total repurchased under its $5 million program to 5,112,000 shares for $1.11 million. Despite the CEO's commitment to the program, citing …

Cosmos Health Share Buyback Expands to 5.11 Million Shares; Continues Open Market Repurchases

Cosmos Health Inc. announced it has repurchased an additional 274,000 shares of its common stock, bringing the total to 5.11 million shares for approximately $1.11 million. The company plans to continue its open market repurchase program, which expires on December 31, 2026, and believes …

Cosmos Health Buys Back 274,000 Shares at About 26 Cents Each

Cosmos Health Inc. (NASDAQ: COSM) announced it repurchased an additional 274,000 shares of its common stock at an average price of approximately $0.2554 per share. This brings the total shares repurchased under its program to 5,112,000 for about $1.11 million, out of an authorized …

Cosmos Health shareholders approved Series B preferred stock designation at annual meeting

Cosmos Health shareholders held their annual meeting on July 15, 2026, where they approved several key proposals. These included ratifying the appointment of the independent registered public accounting firm, adopting the 2026 Equity Omnibus Plan, and authorizing the designation and issuance of 100,000 shares …

Cosmos Health (NASDAQ: COSM) wins backing for Series B preferred and equity plan

Cosmos Health Inc. (NASDAQ: COSM) shareholders approved the designation and issuance of 100,000 shares of Series B Preferred Stock and the company's 2026 Equity Omnibus Plan at their annual meeting on July 15, 2026. Stockholders also elected six directors and ratified the independent registered …

Price to book forward of Cosmos Health Inc – SWB:V67A

This article provides a brief snapshot of the "Price to book forward" for Cosmos Health Inc (SWB:V67A) on the Stuttgart Stock Exchange. It indicates that the market was closed at the time of publication, with no trades reported. The content primarily highlights the financial …

Cosmos Health Share Buyback Surpasses 4.5 Million Shares; Continues Open Market Repurchases

Cosmos Health Inc. announced it has repurchased an additional 100,000 shares of its common stock, bringing the total repurchased under its program to 4,588,000 shares for approximately $970,000. The company plans to continue open market repurchases under the program, which is set to expire …

Cosmos Health repurchases 100,000 shares at $0.29 average

Cosmos Health Inc. has repurchased 100,000 shares of its common stock at an average price of $0.2928 per share, bringing the total repurchases under its $5 million program to 4,588,000 shares. The company's CEO, Greg Siokas, emphasized commitment to the program, which is set …

Cosmos Health Has Spent About $970K on Open-Market Buybacks

Cosmos Health (NASDAQ: COSM) has repurchased an additional 100,000 shares of its common stock, bringing the total to 4,588,000 shares, for approximately $970,000 under its $5 million share repurchase program. The company continues to make open-market repurchases and the program is set to expire …

Cosmo First fixes record date for ₹4 dividend

Cosmo Metals Limited (ASX:CMO): Could Its Funded Drilling Programme at the Yamarna Project Deliver a Catalyst?

Ações da Natura (NATU3) sobem até 6% mesmo após previsão de queda na receita; JP Morgan mantém compra, mas acende alerta

What's Driving Cosmos Exploration's (ASX: C1X) Share Price Lower?

Previsão NATU3 — Preço Alvo para 2027

1318 Forecast — Price Target — Prediction for 2027

Why Cosmos Exploration (ASX:C1X) Shares Are Trading Higher on Tuesday?

Cosmo First to meet analysts on June 23 in Mumbai

Cosmo First sales rise 37%, EBITDA up 53% in Q4FY26

Cosmos Exploration (ASX:C1X) Shares Up 17% Today – Here’s Why

Why is Mao Geping Cosmetics stock down today?

Cosmo First incorporates JV with Filmax Korea

Cosmo First FY26 PAT Rises 17% to Rs 156 Cr

Cosmo First Consolidated March 2026 Net Sales at Rs 1,020.68 crore, up 36.85% Y-o-Y